Anthem Biosciences Limited
Promoter holding in Anthem Biosciences Limited was 71.42% in Jun 2026, down 3.26 points from the previous quarter. Since Jun 2025 it has fallen 3.27 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 71.42%▼3.26 | 28.58%▲3.26 |
| Mar '26 | 74.68%▼0.01 | 25.32%▲0.01 |
| Dec '25 | 74.69%=0.00 | 25.31%=0.00 |
| Sep '25 | 74.69%=0.00 | 25.31%=0.00 |
| Jun '25 | 74.69% | 25.31% |
Trend
- Of the last 4 quarterly changes on record, promoter holding fell in 2 and stayed the same in 2.
- The largest quarterly change was a fall of 3.26 points in the quarter to Jun 2026.
Compared with similar companies
Promoter holding in Anthem Biosciences Limited is higher than 84% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Anthem Biosciences Limited | 71.42% |
| Gland Pharma Limited | 51.77% |
| Ipca Laboratories Limited | 44.72% |
| Ajanta Pharma Limited | 63.48% |
| GlaxoSmithKline Pharmaceuticals Limited | 75.00% |
| Biocon Limited | 44.68% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Anthem Biosciences Limited's promoter holding?
Promoters held 71.42% of Anthem Biosciences Limited as of 30 Jun 2026, and the public held 28.58%.
Has Anthem Biosciences Limited's promoter holding increased?
No, it fell by 3.26 percentage points in the quarter to Jun 2026.
Are any promoter shares of Anthem Biosciences Limited pledged?
No promoter shares are recorded as pledged.
How does Anthem Biosciences Limited's promoter holding compare with similar companies?
Promoter holding in Anthem Biosciences Limited is higher than 84% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.